Ignite Creation Date:
2025-12-24 @ 1:10 PM
Ignite Modification Date:
2026-01-03 @ 11:10 PM
Study NCT ID:
NCT03345095
Status:
COMPLETED
Last Update Posted:
2025-07-01
First Post:
2017-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-26
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-07
First Submit QC Date:
None
Study First Post Date:
2017-11-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-08
Results First Submit QC Date:
None
Results First Post Date:
2024-01-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-26
Last Update Post Date:
2025-07-01
Last Update Post Date Type:
ACTUAL